Day: April 3, 2025

Valeo – voting rights March 2025

Written by Customer Service on April 3, 2025. Posted in Public Companies.

PRESS RELEASEParis, April 3, 2025 Information on the total number of voting rightsand shares forming the share capital(Article L.233-8 II of the French Commercial Code andArticle 223-16 of the General Regulation of the French Financial Markets Authority)DateIssued capitalPar valueTotal number of sharesTotal number of voting rightsTheoretical* Exercisable**March 31, 2025€ 244,633,504 € 1 244,633,504 274,270,662 273,803,785*In accordance with Article 223-11 of the General Regulation of the French Financial Markets Authority, the total number of theoretical voting rights is calculated on the basis of all shares to which voting rights are attached, including shares deprived of voting rights.** The total number of exercisable voting rights is calculated without taking into account shares deprived of voting rights. About...

BW Offshore: Arbitration settlement

Written by Customer Service on April 3, 2025. Posted in Public Companies.

Arbitration settlement BW Offshore Limited (“BW Offshore”) is pleased to report that, in respect of arbitration proceedings between, inter alios, Prio Comercializadora Ltda (previously known as Petro Rio O&G Exploração e Produção de Petróleo Ltda.) (as Claimant) and Prosafe Production B.V. and BW Offshore do Brasil Serviços Marítìmos Ltda (as Respondents) conducted in accordance with the Rules of the London International Court of Arbitration, the parties have, prior to the issuance of a final award, agreed to fully and finally settle the arbitration and the costs of the arbitration in accordance with the terms of a confidential settlement agreement. The financial impact of the settlement agreement, resulting in a payment of approximately USD 36 million to BW Offshore, will be recognised in BW Offshore’s accounts. For further...

Novo Nordisk announces changes in Executive Management

Written by Customer Service on April 3, 2025. Posted in Public Companies.

Bagsværd, Denmark, 3 April 2025 – Novo Nordisk today announced the following changes in Executive Management. After a distinguished career of 28 years with Novo Nordisk, hereof seven years as executive vice president of Commercial Strategy & Corporate Affairs, Camilla Sylvest has decided to leave the company. Consequently, as of 3 April 2025, the following organisational changes are implemented: Ludovic Helfgott, executive vice president, Rare Disease, will assume the responsibility for Product & Portfolio Strategy, including commercial strategy, medical affairs and business development across all therapy areas. Ludovic joined Novo Nordisk in 2019 as executive vice president and has led the establishment of a strategic Rare Disease portfolio. Before joining Novo Nordisk, Ludovic was responsible for the cardiovascular, metabolic...

Stolt-Nielsen Limited Reports Unaudited Results For the First Quarter of 2025

Written by Customer Service on April 3, 2025. Posted in Earnings Releases And Operating Results.

Tanker performance impacted by market uncertainty, non-tanker portfolio continues to perform well LONDON, April 3, 2025 – Stolt-Nielsen Limited (Oslo Børs ticker: SNI) today reported unaudited results for the first quarter ending February 28, 2025. The Company reported a first-quarter net profit of $151.4 million with revenue of $675.6 million, compared with a net profit of $104.0 million with revenue of $707.3 million in the first quarter of 2024. Excluding $75.2 million in one-off gains, due to the step-up of equity investments in Avenir LNG Limited (Avenir) and Hassel Shipping 4 (HS4), first-quarter net profit was $76.2 million. Highlights for the first quarter of 2025, compared with the first quarter of 2024, were:Stolt-Nielsen Limited (SNL) consolidated EBITDA of $192.0 million, down from $210.3 million. Earnings per share (EPS)...

Stolt-Nielsen Limited Announces Intention to Relaunch Share Buy-Back Programme

Written by Customer Service on April 3, 2025. Posted in Public Companies.

LONDON, April 3, 2025 – Stolt-Nielsen Limited (Oslo Børs: SNI) announced today that it intends to continue the share buy-back programme announced on March 2, 2016. Under the 2016 buy-back programme, the Board of Directors had authorised the purchase of up to $30 million worth of the Company’s Common Shares, of which the Company has to date utilised $21,245,172.45, leaving $8,754,827.55 available for further purchases. To comply with the European Market Abuse Regulation, the Company has provided the following required information: the buy-back programme will commence on April 7, 2025, and will remain in effect until the earlier of (i) the acquisition of the maximum number of shares up to the remaining consideration of $8,754,827.55 as set out above, or (ii) October 2, 2025; any share repurchases from and including April 18, 2025 are subject...

URW announces the successful results of the tender offer on its NC2028 Hybrid Notes

Written by Customer Service on April 3, 2025. Posted in Public Companies.

Paris, April 3, 2025 Press release URW announces the successful results of the tender offer on its NC2028 Hybrid Notes UNIBAIL-RODAMCO-WESTFIELD SE (“URW” or the “Group”) announces the results of the tender offer that was launched on March 26, 2025 and expired on April 2, 2025 at 4:00 p.m. (Paris time). €939.2 Mn of the aggregate principal amount of the €995 Mn 7.250% Hybrid Perp-NC 2028 notes (“NC2028 Hybrid Notes”) have been validly tendered, corresponding to a 94.4% participation rate. In line with the Terms and Conditions of the Tender Offer Memorandum, the Group confirms it will accept all validly tendered NC2028 Hybrid Notes for purchase and will proceed with the exercise of its ‘minimal outstanding amount call option’ on the remaining NC2028 Hybrid Notes not tendered. Consequently, the Group will not accept for purchase any of...

Scandinavian Tobacco Group A/S: Financial Calendar 2025

Written by Customer Service on April 3, 2025. Posted in Public Companies.

Company Announcement No. 6/2025 Copenhagen, 3 April 2025 Scandinavian Tobacco Group A/S: Financial Calendar 2025 The financial calendar for 2025 has been revised. Annual General Meeting 9 April 2025 Interim report Q1 2025 20 May 2025 (previously 14 May) Interim report Q2 2025 27 August 2025 Interim report Q3 2025 11 November 2025 For further information, please contact:Torben Sand, Director of IR & External Communication. +45 5084 7222 or torben.sand@st-group.com Eliza Dabbagh, IR and External Communication. +45 5080 7619 or eliza.michael@st-group.comAttachmentCompany Announcement no 6 2025

Diversified Energy Demonstrates Innovation, Collaboration, and Responsibility in 2024 Sustainability Report

Written by Customer Service on April 3, 2025. Posted in Public Companies.

Methane intensity improves by ~13%, a 56% reduction since 2020 Improved personal safety performance across the Company, including a 30% reduction in TRIR from 2023 Activities contributed $1 Billion to state GDPs for a third consecutive year BIRMINGHAM, Ala., April 03, 2025 (GLOBE NEWSWIRE) — Diversified Energy Company PLC (LSE: DEC) (NYSE: DEC) (“Diversified,” “DEC,” or the “Company”) is proud to release its sixth annual Sustainability Report, Winning Through Collaboration, highlighting the Company’s sustainability actions and achievements in 2024. As the champion of the strategy of managing proved, developed, producing (PDP) assets, Diversified is the only publicly traded company dedicated to this approach, leveraging operational scale, vertical integration, and a proprietary technology...

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Written by Customer Service on April 3, 2025. Posted in Mergers And Acquisitions.

Press Release dsm-firmenich completes shareholding increase in Andre Pectin to 90.5% Kaiseraugst (Switzerland), Maastricht (Netherlands), April 3, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, today expanded its investment in Yantai DSM Andre Pectin Company Limited (‘Andre Pectin’), increasing its shareholding to 90.5%. Andre Pectin is a leading specialty food ingredient producer. dsm-firmenich already held 75% of shares in Andre Pectin. Following the latest acquisition of another 15.5% of shares, dsm-firmenich increased its shareholding to 90.5%. The remaining 9.5% of the shares in Andre Pectin continue to be held by Rich Spring Holdings Limited. Announcements to previous related transactions were made on February 4, 2019 and March 18, 2019. Financial details of the transaction will not be disclosed. About dsm-firmenichAs...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Written by Customer Service on April 3, 2025. Posted in Earnings Releases And Operating Results.

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the filing of its Annual Report for the year ended December 31, 2024 (the “Period”). The Annual Report is available under Investors/Financial documents on the Pharming.com website. The Company also announces the filing of its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission (SEC) for the Period. The 2024 Annual Report on Form 20-F can be found under Investors/SEC filings on Pharming.com and through the SEC website once it has been filed. About Pharming Group N.V. Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are...

Day: April 3, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals